Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 05 sector : Health technology save search
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
DMAC | $2.39 13K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: -2.07%
financial results results
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 0.0%
H: 1.65%
C: -0.83%
iot macular elamipretide
ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
ADCT | $4.385 0.34% 110K
|
Health Technology
|
| O: -0.67%
H: 2.95%
C: -1.79%
cancer t-cell
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
MRK | $125.44 -0.59% 2.5M
|
Health Technology
|
| O: 0.14%
H: 2.14%
C: 2.1%
treatment fda positive therapy fda approval her2+ keytruda her2- her2
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published: 2021-05-05 (Crawled : 01:00) - biospace.com/
NVAX | $4.03 -2.18% 2M
|
Health Technology
|
| O: 3.47%
H: 4.31%
C: -8.13%
covid phase 2 results vaccine phase 2b trial trial results
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.
Published: 2021-05-05 (Crawled : 22:00) - prnewswire.com
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 1.74%
H: 1.71%
C: -3.76%
acquisition
Minerva Neurosciences to Report First Quarter 2021 Financial Results and Business Updates on May 12, 2021
Published: 2021-05-05 (Crawled : 22:00) - globenewswire.com
NERV | $2.59 7.03% 57K
|
Health Technology
|
| O: -1.26%
H: 0.0%
C: -4.26%
financial results results
vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
Published: 2021-05-05 (Crawled : 21:00) - ir.vtvtherapeutics.com
RPHM | $1.66 30K
|
Professional, Scientific, and T...
|
| O: 0.68%
H: 0.24%
C: -0.07%
VTVT | $25.0 750
|
Health Technology
|
| O: -0.41%
H: 2.07%
C: -1.65%
financial results results
Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome
Published: 2021-05-05 (Crawled : 21:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 1.61%
H: 1.13%
C: -9.48%
phase 3 trial syndros designation zygel
Danaher Announces Quarterly Dividends
Published: 2021-05-05 (Crawled : 21:00) - prnewswire.com
DHR | $240.78 0.47% 1.3M
|
Health Technology
|
| O: -0.33%
H: 1.39%
C: 1.31%
Manager, Contracts Administration & Legal Affairs
Published: 2021-05-05 (Crawled : 21:00) - sutrobio.com
STRO M | $4.005 -3.26% 310K
|
Health Technology
|
| O: -1.6%
H: 2.51%
C: -2.99%
contract
$95.7 Million Worldwide Fiducial Markers Industry to 2027 - Impact of COVID-19 on the Market
Published: 2021-05-05 (Crawled : 21:00) - prnewswire.com
BSX | $68.395 1.42% 2.3M
|
Health Technology
|
| O: -0.14%
H: 0.17%
C: 0.02%
covid covid-19
Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-05 (Crawled : 21:00) - ampiopharma.com
AMPE | $0.62 53K
|
Health Technology
|
| O: -2.78%
H: 0.57%
C: -1.71%
financial results results
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-05-05 (Crawled : 21:00) - globenewswire.com
TBIO | $0.386 -5.85% 3.5K
|
Health Technology
|
| O: -3.57%
H: 0.0%
C: -11.06%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: 0.55%
H: 0.51%
C: 0.29%
granted grant
Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders
Published: 2021-05-05 (Crawled : 21:00) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -0.16%
results
Cytokinetics to Hold Annual Meeting of Stockholders
Published: 2021-05-05 (Crawled : 20:00) - globenewswire.com
CYTK | $70.01 2.96% 500K
|
Health Technology
|
| O: -1.36%
H: 1.55%
C: 0.47%
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference
Published: 2021-05-05 (Crawled : 20:00) - investor.alkermes.com
ALKS | $23.85 -0.71% 530K
|
Health Technology
|
| O: -0.68%
H: 1.64%
C: 0.5%
conference
Global Elastography Imaging Industry (2020 to 2027) - Market Trajectory & Analytics
Published: 2021-05-05 (Crawled : 19:00) - prnewswire.com
PHG | $20.33 -0.39% 490K
|
Health Technology
|
| O: 0.45%
H: 0.05%
C: -0.02%
GE | $155.8 1.37% 2.9M
|
Electronic Technology
|
| O: 0.08%
H: 0.68%
C: -0.08%
analytics imaging
Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results
Published: 2021-05-05 (Crawled : 19:00) - prnewswire.com
AXDX M | $0.899 -1.21% 26K
|
Health Technology
|
| O: -0.28%
H: 1.72%
C: 0.62%
results diagnostics diagnostic
Eduardo Pennella, M.D.
Published: 2021-05-05 (Crawled : 19:00) - aravive.com
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.2%
H: 2.75%
C: -5.1%
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.